Allograft Clinical Trial
Official title:
RElapse After Allograft: Link Between LoCus of Control and QualiTy of Life: REACT Study
Allogeneic hematopoietic transplantation (AlloHCT) is a robust therapeutic that is used as a consolidation strategy in a number of haematological cancers. It provides durable responses as compared to chemotherapy alone. Despite the potential of the graft-versus-tumor effect that is driven by AlloHCT, relapse after AlloHCT remains common. Yet, the psychological impact of relapse after allograft is poorly appreciated.
For patients with hematological cancers of poor prognosis (acute myeloid leukemia, myelodysplastic syndromes…), proceeding to allogeneic hematopoietic transplantation (AlloHCT) is the definitive curative approach. While AlloHCT is an invasive procedure, patients experience social isolation and distressing symptoms when hospitalized. Indeed, patients often report high levels of anxiety and/or depression during hospitalization and upon discharge. A number of risk factors have been linked to psychological morbidity and their impact on post-AlloHCT relapse have been less investigated. Of note, the health locus of control may play a significant role in determining patients' health-related behaviors. The health locus of control is defined as the set of beliefs a person has about his or her personal influence on health, including an internal locus of control (i.e. personal actions or thoughts can affect outcomes) and an external locus of control (i.e. outcome is believed to be determined by powerful others: God, health professionals, chance…). In this context, the aim of the study REACT is to identify the types of locus of control in relapsed patients after AlloHCT and the possible association with current disease perception as well as further therapeutic strategies. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05536492 -
Sticky Bone Compared to A-PRF(Platlet Rich Fibrin) Effect on Alveolar Ridge Preservation
|
N/A | |
| Completed |
NCT00384540 -
Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling
|
N/A | |
| Recruiting |
NCT02882828 -
PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)
|
Phase 4 | |
| Completed |
NCT02444052 -
Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
|
N/A | |
| Terminated |
NCT04021316 -
Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration
|
N/A | |
| Completed |
NCT00894049 -
A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation
|
Phase 2 | |
| Recruiting |
NCT03402776 -
Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation
|
Phase 3 | |
| Completed |
NCT03829072 -
Cooking Education and Adapted Physical Activity in Allografted Patients
|
N/A | |
| Completed |
NCT03009708 -
Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen
|
N/A | |
| Recruiting |
NCT05096351 -
Immunological Reaction of the Recipient After Cold-stored Saphenous Venous Allograft (Bioprotec)
|
||
| Not yet recruiting |
NCT05459181 -
HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
|
N/A | |
| Recruiting |
NCT05164835 -
Study of Drug Acceptance and Its Persistence Over Time in Patients Receiving a Haematopoietic Stem Cell Allograft
|
N/A | |
| Recruiting |
NCT05510011 -
Allograft and Tantalum Cone Reconstruction in TKA Revision
|
||
| Not yet recruiting |
NCT06219473 -
Efficacy of Fascia Lata Allograft and Platelet Rich Fibrin on the Periodontal Phenotype Around Dental Implant
|
Phase 4 | |
| Withdrawn |
NCT05423496 -
KidneyCare Immuno-optimization in Renal Allografts (KIRA)
|
N/A | |
| Completed |
NCT00876148 -
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting
|
N/A |